Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
Horby PW. et al, (2025), Lancet Infectious Diseases
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2025), The Lancet Infectious Diseases
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial
Cooke GS. et al, (2025), The Lancet, 405, 1769 - 1780
Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis
Huynh J. et al, (2025), BMJ Open, 15, e088543 - e088543
A modified decontamination and storage method for sputum from patients with tuberculosis
Le Quang N. et al, (2025), Wellcome Open Research, 8, 166 - 166
Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis
Donovan J. et al, (2025), Wellcome Open Research, 9, 695 - 695
Advancing the chemotherapy of tuberculous meningitis: a consensus view.
Wasserman S. et al, (2025), The Lancet. Infectious diseases, 25, e47 - e58
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Phong NT. et al, (2024), Wellcome Open Research, 9, 543 - 543
A description of lineage 1 Mycobacterium tuberculosis from papua, Indonesia.
Djunaedy HAK. et al, (2024), Tuberculosis (Edinburgh, Scotland), 149
Correction: Aetiology and Potential Animal Exposure in Central Nervous System Infections in Vietnam
Brindle HE. et al, (2024), EcoHealth, 21, 210 - 212
Validating the ratio of insulin like growth factor binding protein 4 to sex hormone binding globulin as a prognostic predictor of preterm birth in Viet Nam: a case-cohort study.
Hirst JE. et al, (2024), The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 37
Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis
Donovan J. et al, (2024), Wellcome Open Research, 9, 695 - 695
Emerging Monkeypox Virus Sublineage C.1 Causing Community Transmission, Vietnam, 2023.
Hoa HTT. et al, (2024), Emerging infectious diseases, 30, 2385 - 2390
WHO global research priorities for antimicrobial resistance in human health
Bertagnolio S. et al, (2024), The Lancet Microbe, 5, 100902 - 100902
Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis
Hai HT. et al, (2024), eLife, 13
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis.
Hai HT. et al, (2024), eLife, 13
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Phong NT. et al, (2024), Wellcome Open Research, 9, 543 - 543
Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal study
Vijay S. et al, (2024), eLife, 13